{"id":20,"date":"2025-02-12T15:12:51","date_gmt":"2025-02-12T15:12:51","guid":{"rendered":"http:\/\/www.vampire-eu.com\/home\/"},"modified":"2025-06-17T15:57:30","modified_gmt":"2025-06-17T15:57:30","slug":"home-2","status":"publish","type":"page","link":"https:\/\/www.vampire-eu.com\/fr\/","title":{"rendered":"Accueil"},"content":{"rendered":"
\n

V\u03b1MPiRE
Validation des modifications de l\u2019\u03b1-synucl\u00e9ine dans l\u2019\u00e9volution de la maladie de Parkinson<\/h2><\/div><\/div><\/div><\/div>\n<\/div><\/div>\n\n\n\n
\n

V\u03b1MPiRE en un coup d\u2019\u0153il<\/h2><\/div>

La maladie de Parkinson (MP) est un trouble neurod\u00e9g\u00e9n\u00e9ratif progressif qui touche plus de 9,4 millions de personnes dans le monde, un chiffre qui pourrait d\u00e9passer les 12 millions d\u2019ici 2040. Malgr\u00e9 les avanc\u00e9es, le diagnostic pr\u00e9coce et le traitement demeurent difficiles en raison de l\u2019absence de biomarqueurs fiables. Les prot\u00e9ines \u03b1-synucl\u00e9ine mal repli\u00e9es jouent un r\u00f4le cl\u00e9 dans la pathologie de la MP et sont apparues comme des cibles diagnostiques prometteuses. Le projet V\u03b1MPiRE, financ\u00e9 par l\u2019UE, \u00e9tudiera les isoformes de l\u2019\u03b1-synucl\u00e9ine dans les v\u00e9sicules extracellulaires d\u2019origine neuronale, issues d\u2019une large cohorte de patients atteints de la MP et de t\u00e9moins non atteints. Les r\u00e9sultats du projet contribueront au d\u00e9veloppement d\u2019un nouveau test de diagnostic in vitro (IVD) pour la d\u00e9tection pr\u00e9coce de la MP et le suivi de sa progression. Cette innovation pourrait am\u00e9liorer le d\u00e9pistage pr\u00e9coce, la d\u00e9tection, la gestion de la maladie et les r\u00e9sultats pour les patients, afin de mettre au point de meilleurs traitements.<\/p><\/div><\/div><\/div>\n\n\n\n

<\/div>

Un d\u00e9pistage am\u00e9lior\u00e9 de la maladie de Parkinson permettra une d\u00e9tection plus pr\u00e9coce pour 270 000 nouveaux cas annuels, ainsi qu\u2019une meilleure prise en charge des 9,4 millions de personnes actuellement diagnostiqu\u00e9es. Cela permettra d\u2019\u00e9viter la perte de 5,8 millions d\u2019ann\u00e9es de vie ajust\u00e9es sur l\u2019incapacit\u00e9 (DALYs) d\u2019ici 2028 et facilitera le d\u00e9veloppement de traitements plus efficaces.<\/em><\/em><\/em><\/em><\/em><\/p><\/div><\/div><\/div>\n\n\n\n

\n

Nous recrutons des participants pour notre essai clinique !<\/a><\/strong><\/h3><\/div>

Que vous ayez la maladie de Parkinson ou non, vous pouvez nous aider \u00e0 faire progresser la d\u00e9tection pr\u00e9coce de la maladie<\/a><\/p><\/div><\/div><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

\n

Un changement de paradigme dans la lutte contre la maladie de Parkinson<\/h2><\/div><\/div><\/div>\n\n\n\n
\n
\n
\n
\"\"<\/figure><\/div>\n<\/div>\n\n\n\n
\n
<\/div>

La maladie de Parkinson (MP) touche des millions de personnes dans le monde, sa nature progressive laissant patients et aidants dans une lutte constante contre ses effets invalidants. Malgr\u00e9 des ann\u00e9es de recherche, l\u2019absence d\u2019outils de diagnostic pr\u00e9coce et de biomarqueurs efficaces nous maintient un pas en arri\u00e8re dans ce combat. Aujourd\u2019hui, V\u03b1MPiRE, notre initiative r\u00e9volutionnaire, est sur le point de changer la donne.

Ce projet visionnaire vise \u00e0 r\u00e9volutionner la d\u00e9tection pr\u00e9coce, le pronostic et la prise en charge de la maladie de Parkinson gr\u00e2ce \u00e0 une science de pointe et \u00e0 l\u2019innovation.<\/p><\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/div>

La d\u00e9tection pr\u00e9coce r\u00e9invent\u00e9e<\/strong><\/h3><\/div>

En tirant parti des d\u00e9couvertes r\u00e9centes, nous \u00e9tudierons les isoformes de l\u2019\u03b1-synucl\u00e9ine (\u03b1-Syn) et les biomarqueurs pr\u00e9sents dans les v\u00e9sicules extracellulaires d\u2019origine neuronale (NDEV), en utilisant des \u00e9chantillons sanguins de 1 200 participants. Notre approche est con\u00e7ue pour r\u00e9v\u00e9ler les premiers signes de la maladie de Parkinson.<\/p><\/div><\/div><\/div>\n\n\n\n

\"\"<\/div>

Des analyses renforc\u00e9es par l\u2019IA<\/strong><\/h3><\/div>

En utilisant des algorithmes avanc\u00e9s d\u2019intelligence artificielle (IA), nous transformerons des donn\u00e9es complexes de biomarqueurs en outils diagnostiques exploitables, garantissant pr\u00e9cision et fiabilit\u00e9 dans des conditions cliniques r\u00e9elles.<\/p><\/div><\/div><\/div>\n\n\n\n

\"\"<\/div>

Un effort collaboratif<\/strong><\/h3><\/div>

En collaboration avec des laboratoires de premier plan et des fabricants de dispositifs m\u00e9dicaux de diagnostic in vitro (DIV), nous visons \u00e0 cr\u00e9er et valider un test DIV innovant. Ce prototype permettra d\u2019identifier la maladie de Parkinson \u00e0 ses tout premiers stades, d\u2019estimer la progression de la maladie et de surveiller la r\u00e9ponse au traitement.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

\n
\n

Rejoignez-nous dans ce voyage transformateur<\/h2><\/div>

V\u03b1MPiRE repr\u00e9sente bien plus qu\u2019un projet ; c\u2019est un mouvement visant \u00e0 red\u00e9finir notre lutte contre la maladie de Parkinson. Construisons ensemble l\u2019avenir, en ouvrant la voie \u00e0 des interventions plus pr\u00e9coces, de meilleurs traitements et de l\u2019espoir pour des millions de personnes.<\/p><\/div><\/div>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/div>

R\u00e9volutionner la d\u00e9tection pr\u00e9coce et le pronostic de la maladie de Parkinson<\/strong><\/h3><\/div>

Gr\u00e2ce \u00e0 des \u00e9tudes longitudinales rigoureuses, des contr\u00f4les mensuels et des m\u00e9thodes de validation de pointe, V\u03b1MPiRE garantira que le test d\u00e9velopp\u00e9 non seulement d\u00e9tecte pr\u00e9cocement la maladie de Parkinson, mais aide \u00e9galement \u00e0 pr\u00e9voir sa progression et les r\u00e9sultats du traitement avec une pr\u00e9cision sans pr\u00e9c\u00e9dent.
L\u2019\u00e9tude longitudinale comprend un suivi de 24 mois des participants atteints de la maladie de Parkinson ainsi que des t\u00e9moins, recrut\u00e9s selon une m\u00e9thodologie cas-t\u00e9moins ajust\u00e9e en grappes.
Pendant cette p\u00e9riode, les deux cohortes seront suivies \u00e0 l\u2019aide d\u2019enqu\u00eates mensuelles sur leur progression. Cela permettra de valider non seulement la puissance statistique de la d\u00e9tection de la maladie de Parkinson, mais aussi la progression de la maladie et la r\u00e9ponse au traitement.
De plus, environ 5% des personnes initialement recrut\u00e9es en tant que sujets non atteints de la maladie de Parkinson devraient d\u00e9velopper la maladie. Cela permettra d\u2019\u00e9valuer la capacit\u00e9 de d\u00e9tection \u00e0 des stades tr\u00e8s pr\u00e9coces.<\/p><\/div><\/div><\/div>\n\n\n\n

\"\"<\/div>

Transformer le diagnostic de la maladie de Parkinson : accessible, abordable et efficace<\/strong><\/h3><\/div>

Nous envisageons un avenir o\u00f9 le diagnostic pr\u00e9coce de la maladie de Parkinson sera accessible, abordable et r\u00e9volutionnaire. Notre consortium s\u2019engage \u00e0 transformer ces avanc\u00e9es en solutions commercialis\u00e9es qui b\u00e9n\u00e9ficieront aux patients et aux syst\u00e8mes de sant\u00e9 du monde entier.<\/p><\/div><\/div><\/div>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

\n
\n
\n
\"\"<\/figure><\/div>\n<\/div>\n\n\n\n
\n

Ce projet a re\u00e7u un financement dans le cadre du programme HORIZON-HLTH-2024-DISEASE-03 \u00e0 deux \u00e9tapes de l\u2019Union europ\u00e9enne. grant agreement No 101156370<\/a>.
Les points de vue et opinions exprim\u00e9s sont toutefois ceux de l\u2019auteur ou des auteurs uniquement et ne refl\u00e8tent pas n\u00e9cessairement ceux de l\u2019Union europ\u00e9enne ou de HORIZON-RIA. Ni l\u2019Union europ\u00e9enne ni l\u2019autorit\u00e9 de financement ne peuvent \u00eatre tenues responsables.<\/p>\n<\/div>\n<\/div>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"full-width-container","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"enabled","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-20","page","type-page","status-publish","hentry"],"yoast_head":"\nHome - V\u03b1MPiRE<\/title>\n<meta name=\"description\" content=\"Parkinson's disease early detection\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vampire-eu.com\/fr\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Home - V\u03b1MPiRE\" \/>\n<meta name=\"twitter:description\" content=\"Parkinson's disease early detection\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/Brain.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vampire-eu.com\/\",\"url\":\"https:\/\/www.vampire-eu.com\/\",\"name\":\"Home - V\u03b1MPiRE\",\"isPartOf\":{\"@id\":\"https:\/\/www.vampire-eu.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.vampire-eu.com\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.vampire-eu.com\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/Brain.jpg\",\"datePublished\":\"2025-02-12T15:12:51+00:00\",\"dateModified\":\"2025-06-17T15:57:30+00:00\",\"description\":\"Parkinson's disease early detection\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vampire-eu.com\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vampire-eu.com\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.vampire-eu.com\/#primaryimage\",\"url\":\"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/Brain.jpg\",\"contentUrl\":\"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/Brain.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vampire-eu.com\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.vampire-eu.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Home\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vampire-eu.com\/#website\",\"url\":\"https:\/\/www.vampire-eu.com\/\",\"name\":\"V\u03b1MPiRE\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.vampire-eu.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vampire-eu.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vampire-eu.com\/#organization\",\"name\":\"V\u03b1MPiRE\",\"url\":\"https:\/\/www.vampire-eu.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.vampire-eu.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/cropped-cropped-V\u03b1MPiRE.png\",\"contentUrl\":\"https:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/cropped-cropped-V\u03b1MPiRE.png\",\"width\":512,\"height\":512,\"caption\":\"V\u03b1MPiRE\"},\"image\":{\"@id\":\"https:\/\/www.vampire-eu.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/showcase\/biosomics\/about\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Home - V\u03b1MPiRE","description":"Parkinson's disease early detection","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vampire-eu.com\/fr\/","twitter_card":"summary_large_image","twitter_title":"Home - V\u03b1MPiRE","twitter_description":"Parkinson's disease early detection","twitter_image":"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/Brain.jpg","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vampire-eu.com\/","url":"https:\/\/www.vampire-eu.com\/","name":"Home - V\u03b1MPiRE","isPartOf":{"@id":"https:\/\/www.vampire-eu.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vampire-eu.com\/#primaryimage"},"image":{"@id":"https:\/\/www.vampire-eu.com\/#primaryimage"},"thumbnailUrl":"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/Brain.jpg","datePublished":"2025-02-12T15:12:51+00:00","dateModified":"2025-06-17T15:57:30+00:00","description":"Parkinson's disease early detection","breadcrumb":{"@id":"https:\/\/www.vampire-eu.com\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vampire-eu.com\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.vampire-eu.com\/#primaryimage","url":"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/Brain.jpg","contentUrl":"http:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/Brain.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.vampire-eu.com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vampire-eu.com\/"},{"@type":"ListItem","position":2,"name":"Home"}]},{"@type":"WebSite","@id":"https:\/\/www.vampire-eu.com\/#website","url":"https:\/\/www.vampire-eu.com\/","name":"V\u03b1MPiRE","description":"","publisher":{"@id":"https:\/\/www.vampire-eu.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vampire-eu.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.vampire-eu.com\/#organization","name":"V\u03b1MPiRE","url":"https:\/\/www.vampire-eu.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.vampire-eu.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/cropped-cropped-V\u03b1MPiRE.png","contentUrl":"https:\/\/www.vampire-eu.com\/wp-content\/uploads\/2025\/02\/cropped-cropped-V\u03b1MPiRE.png","width":512,"height":512,"caption":"V\u03b1MPiRE"},"image":{"@id":"https:\/\/www.vampire-eu.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/showcase\/biosomics\/about"]}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"Pedro Sanchez","author_link":"https:\/\/www.vampire-eu.com\/fr\/author\/slpedro\/"},"uagb_comment_info":0,"uagb_excerpt":null,"_links":{"self":[{"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/pages\/20","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/comments?post=20"}],"version-history":[{"count":146,"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/pages\/20\/revisions"}],"predecessor-version":[{"id":5456,"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/pages\/20\/revisions\/5456"}],"wp:attachment":[{"href":"https:\/\/www.vampire-eu.com\/fr\/wp-json\/wp\/v2\/media?parent=20"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}